section name header

Pronunciation

par-oh-moeMYE-sin

Classifications

Therapeutic Classification: amebicide

Indications

REMS


Action

  • Inhibits protein synthesis in bacteria at level of 30S ribosome.
Therapeutic effects:
  • Resolution of amebic infections.

Spectrum:

Pharmacokinetics

Absorption: Minimal to no systemic absorption.

Distribution: Unknown.

Metabolism/Excretion: 100% excreted in feces.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
POunknownunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GI: abdominal cramps, diarrhea, nausea, vomiting

Misc: hypersensitivity reactions

Interactions

Interactions are listed for systemically absorbed drug

Route/Dosage

Intestinal Amebiasis

Hepatic Coma

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes